Literature DB >> 748802

Influence of surgery, irradiation, chemotherapy, and immunotherapy on growth of a metastasizing rat mammary adenocarcinoma.

A E Bogden, H J Esber.   

Abstract

Based upon the hypothesis that a factor most pertinent to the absence of an effective immune response in cancer is the inadequacy of the antigenic stimulus provided by the neoplasm, either in terms of weak immunogenicity of the tumor antigen or of the necessary antigen mass available to the reticuloendothelial tissues at any one time for effective sensitization, the host immune response capabilities were stimulated within a time frame synchronous with a greater release of tumor antigens. In the treatment of a metastasizing, solid tumor model syngeneic with F344 rats, immunotherapy was most effectively applied in combinations with chemotherapy and/or localized radiotherapy, therapeutic modalities that induced a degree of oncolysis and tumor resorption. Surgery combined with chemotherapy permitted evaluation of therapeutic effects against metastases. The methanol-soluble fraction of Mycobacterium butyricum was used as the nonspecific immunologic adjuvant.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 748802

Source DB:  PubMed          Journal:  Natl Cancer Inst Monogr        ISSN: 0083-1921


  4 in total

1.  Lymphatic metastasis; lymphangiochemotherapy of mammary cancer: ascitic form of rat mammary adenocarcinoma 13762.

Authors:  J Carr; B Dreher; I Carr
Journal:  Clin Exp Metastasis       Date:  1983 Jan-Mar       Impact factor: 5.150

2.  An experimental model of leptomeningeal metastases employing rat mammary carcinoma cells.

Authors:  S M Sagar; K J Price
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

3.  Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death.

Authors:  Abhishek D Garg; Lorenzo Galluzzi; Lionel Apetoh; Thais Baert; Raymond B Birge; José Manuel Bravo-San Pedro; Karine Breckpot; David Brough; Ricardo Chaurio; Mara Cirone; An Coosemans; Pierre G Coulie; Dirk De Ruysscher; Luciana Dini; Peter de Witte; Aleksandra M Dudek-Peric; Alberto Faggioni; Jitka Fucikova; Udo S Gaipl; Jakub Golab; Marie-Lise Gougeon; Michael R Hamblin; Akseli Hemminki; Martin Herrmann; James W Hodge; Oliver Kepp; Guido Kroemer; Dmitri V Krysko; Walter G Land; Frank Madeo; Angelo A Manfredi; Stephen R Mattarollo; Christian Maueroder; Nicolò Merendino; Gabriele Multhoff; Thomas Pabst; Jean-Ehrland Ricci; Chiara Riganti; Erminia Romano; Nicole Rufo; Mark J Smyth; Jürgen Sonnemann; Radek Spisek; John Stagg; Erika Vacchelli; Peter Vandenabeele; Lien Vandenberk; Benoit J Van den Eynde; Stefaan Van Gool; Francesca Velotti; Laurence Zitvogel; Patrizia Agostinis
Journal:  Front Immunol       Date:  2015-11-20       Impact factor: 7.561

Review 4.  Ferroptosis, necroptosis, and pyroptosis in anticancer immunity.

Authors:  Rong Tang; Jin Xu; Bo Zhang; Jiang Liu; Chen Liang; Jie Hua; Qingcai Meng; Xianjun Yu; Si Shi
Journal:  J Hematol Oncol       Date:  2020-08-10       Impact factor: 17.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.